Top Markets
Coin of the day
Original BioMedicals Co., Ltd. Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd.

6483
Rang in Aktien #27912
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Aktienkurs
$0.44677634
Marktkapitalisierung
$29.85M
Veränderung (1 Tag)
0.36%
Veränderung (1 Jahr)
-2.97%
Land
TW
Handel Original BioMedicals Co., Ltd. (6483)

Kategorie

Dividendenhistorie für Original BioMedicals Co., Ltd. (6483)
Original BioMedicals Co., Ltd. (Aktienkürzel: 6483) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Original BioMedicals Co., Ltd. (6483) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber